HangAmDan-B, an ethnomedicinal herbal mixture, suppresses inflammatory responses by inhibiting Syk/NF-κB and JNK/ATF-2 pathways

Journal of Medicinal Food

Volumn 16, Issue 1, 2013, Pages 56-65

  Yu, Tao ^a   Moh, Sang Hyun ^b   Kim, Sang Bom ^c   Yang, Yanyan ^a   Kim, Eunji ^a   Lee, Yeon Weol ^c   Cho, Chong Kwan ^c   Kim, Kyung Hee ^d   Yoo, Byong Chul ^d   Cho, Jae Youl ^a   Yoo, Hwa Seung ^c  

^a Sungkyunkwan University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Daejeon University   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

ATF 2; HangAmDan B; inflammation; macrophages; NF B; p38; Syk

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; ACTIVATING TRANSCRIPTION FACTOR 2; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; HANGAMDAN B; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN KINASE SYK; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; ANTI-INFLAMMATORY AGENTS; DOWN-REGULATION; DRUGS, CHINESE HERBAL; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAP KINASE KINASE 4; MICE; MICE, INBRED ICR; NF-KAPPA B; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 84872119707     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2374     Document Type: Article

References (58)

1. Aggarwal BB, Shishodia S, Takada Y, Jackson-Bernitsas D, Ahn KS, Sethi G, Ichikawa H: TNF blockade: an inflammatory issue. Ernst Schering Res Found Workshop 2006:161-186.
2. Allam R, Anders HJ: The role of innate immunity in autoimmune tissue injury. Curr Opin Rheumatol 2008;20:538-544.
3. O'Neill LA, Fitzgerald KA, Bowie AG: The toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 2003;24:286-290.
4. O'Neill LA: The role of MyD88-like adapters in toll-like re-ceptor signal transduction. Biochem Soc Trans 2003;31:643-647. (Pubitemid 36750747)
5. Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Mar-tinez JA: Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 2009;58:537-552.
6. Konoshima T, Takasaki M, Tokuda H: Anti-carcinogenic activity of the roots of Panax notoginseng. II. Biol Pharm Bull 1999;22:1150-1152. (Pubitemid 29507965)
7. Yoo HS, Yoon J, Lee GH, Lee YW, Cho CK: Best case series program supportive cases of Cordyceps militaris- and panax notoginseng-based anticancer herbal formula. Integr Cancer Ther 2011;10:NP1-3.
8. Xia WB, Xue Z,LiS, Wang SJ, Yang YC, He DX, Ran GL, Kong LZ, Shi JG: Chemical constituents from tuber of Cremastra ap-pendiculata. Zhongguo Zhong Yao Za Zhi 2005;30:1827-1830.
9. Sohn J, Lee CH, Chung DJ, Park SH, Kim I, Hwang WI: Effect of petroleum ether extract of Panax ginseng roots on prolifera-tion and cell cycle progression of human renal cell carcinoma cells. Exp Mol Med 1998;30:47-51. (Pubitemid 28181772)
10. Frank MB, Yang Q, Osban J, Azzarello JT, Saban MR, Saban R, Ashley RA, Welter JC, Fung KM, Lin HK: Frankincense oil derived from Boswellia carteri induces tumor cell specific cy-totoxicity. BMC Complement Altern Med 2009;9:6.
11. Shoemaker M, Hamilton B, Dairkee SH, Cohen I, Campbell MJ: In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res 2005;19:649-651. (Pubitemid 41375251)
12. Choi YJ, Shin DY, Lee YW, Cho CK, Kim GY, Kim WJ, Yoo HS, Choi YH: Inhibition of cell motility and invasion by HangAmDan-B in NCI-H460 human non-small cell lung cancer cells. Oncol Rep 2011;26:1601-1608.
13. Bang JY, Kim KS, Kim EY, Yoo HS, Lee YW, Cho CK, Choi Y, Jeong HJ, Kang IC: Anti-angiogenic effects of the water extract of HangAmDan (WEHAD), a Korean traditional medicine. Sci China Life Sci 2011;54:248-254.
14. Yoo HS, Cho CK, Hong MS: Review of the best case series methodology: best case series results of East-West Cancer Cen-ter. Integr Cancer Ther 2008;7:182-188.
15. Jeong HJ, Lee JY, Kim JB, Go H, Ko SG, Seo YW, Jeong S, Park J, Na HJ, Um JY, Kim HM, Hong SH: Induction of apoptosis by KI0477959 through activation of caspase-3 in human leukemia cell line, HL-60 cells. Int J Neurosci 2008;118:1384-1399.
16. Yoo HS, Lee HJ, Kim JS, Yoon J, Lee GH, Lee YW, Cho CK: A toxicological study of HangAmDan-B in mice. J Acupunct Meridian Stud 2011;4:54-60.
17. Raz A, Levine G, Khomiak Y: Acute local inflammation po-tentiates tumor growth in mice. Cancer Lett 2000;148:115-120. (Pubitemid 30047097)
18. Correa M, Machado J Jr., Carneiro CR, Pesquero JB, Bader M, Travassos LR, Chammas R, Jasiulionis MG: Transient inflam-matory response induced by apoptotic cells is an important me-diator of melanoma cell engraftment and growth. Int J Cancer 2005;114:356-363. (Pubitemid 40279954)
19. Bauer AK, Dwyer-Nield LD, Keil K, Koski K, Malkinson AM: Butylated hydroxytoluene (BHT) induction of pulmonary in-flammation: a role in tumor promotion. Exp Lung Res 2001;27:197-216. (Pubitemid 32239293)
20. Yang H, Lee SE, Jeong SI, Park CS, Jin YH, Park YS: Up-regulation of heme oxygenase-1 by Korean red ginseng water extract as a cytoprotective effect in human endothelial cells. J Ginseng Res 2011;35:352-359.
21. Cho JY, Baik KU, Jung JH, Park MH: In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. Eur J Pharmacol 2000;398:399-407. (Pubitemid 30349105)
22. Jang SA, Kang SC, Sohn EH: Phagocytic effects of beta-glucans from the mushroom Coriolus versicolor are related to dectin-1, NOS, TNF-alpha signaling in macrophages. Biomol Ther 2011; 19:438-444.
23. Shen T, Lee J, Lee E, Kim SH, Kim TW, Cho JY: Cafestol, a coffee-specific diterpene, is a novel extracellular signal-regulated kinase inhibitor with AP-1-targeted inhibition of prostaglandin E2 production in lipopolysaccharide- activated macrophages. Biol Pharm Bull 2010;33:128-132.
24. Yayeh T, Jung KH, Jeong HY, Park JH, Song YB, Kwak YS, Kang HS, Cho JY, Oh JW, Kim SK, Rhee MH: Korean red ginseng saponin fraction downregulates proinflammatory medi-ators in LPS stimulated RAW264.7 cells and protects mice against endotoxic shock. J Ginseng Res 2012;36:263-269.
25. Lee YG, Lee WM, Kim JY, Lee JY, Lee IK, Yun BS, Rhee MH, Cho JY: Src kinase-targeted anti-inflammatory activity of da-vallialactone from Inonotus xeranticus in lipopolysaccharide-activated RAW264.7 cells. Br J Pharmacol 2008;154:852-863. (Pubitemid 351821587)
26. Lee H, Kim J, Lee SY, Park JH, Hwang GS: Processed Panax ginseng, sun ginseng, decreases oxidative damage induced by tert-butyl hydroperoxide via regulation of antioxidant enzyme and anti-apoptotic molecules in HepG2 cells. J Ginseng Res 2012;36:248-255.
27. Yoo DS, Rho HS, Lee YG, Yeom MH, Kim DH, Lee SJ, Hong S, Lee J, Cho JY: Ginsenoside F1 modulates cellular responses of skin melanoma cells. J Ginseng Res 2011;35:86-91.
28. Okabe S, Miyake H, Awane Y: Cytoprotective effects of NC-1300 and omeprazole on HCl/ethanol-induced gastric lesions in rats. Jpn J Pharmacol 1986;42:123-133. (Pubitemid 16053847)
29. Kim P, Jeong CS: Effects of Chenopodium album Linne on gastritis and gastric cancer cell growth. Biomol Ther 2011;19: 487-492.
30. Aguirre-Hernandez E, Gonzalez-Trujano ME, Martinez AL, Moreno J, Kite G, Terrazas T, Soto-Hernandez M: HPLC/MS analysis and anxiolytic-like effect of quercetin and kaempferol flavonoids from Tilia americana var. mexicana. J Ethno-pharmacol 2010;127:91-97.
31. Lee DY, Cho JG, Lee MK, Lee JW, Lee YH, Yang DC, Baek NI: Discrimination of Panax ginseng roots cultivated in different areas in Korea using HPLC-ELSD and principal component analysis. J Ginseng Res 2011;35:31-38.
32. Chang LC, Tsao LT, Chang CS, Chen CJ, Huang LJ, Kuo SC, Lin RH, Wang JP: Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer-binding protein activation in microglia. Biochem Pharmacol 2008;76:507-519.
33. Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G: Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol 2002; 64:963-970. (Pubitemid 35232270)
34. Lee YG, Byeon SE, Kim JY, Lee JY, Rhee MH, Hong S, Wu JC, Lee HS, Kim MJ, Cho DH, Cho JY: Immunomodulatory effect of Hibiscus cannabinus extract on macrophage functions. J Ethno-pharmacol 2007;113:62-71. (Pubitemid 47077848)
35. Lee HJ, Hyun EA, Yoon WJ, Kim BH, Rhee MH, Kang HK, Cho JY, Yoo ES: In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts. J Ethnopharmacol 2006; 103:208-216. (Pubitemid 41796919)
36. Yu T, Lee YJ, Jang HJ, Kim AR, Hong S, Kim TW, Kim MY, Lee J, Lee YG, Cho JY: Anti-inflammatory activity of Sorbus commixta water extract and its molecular inhibitory mechanism. J Ethnopharmacol 2011;134:493-500.
37. Yu T, Lee YJ, Yang HM, Han S, Kim JH, Lee Y, Kim C, Han MH, Kim MY, Lee J, Cho JY: Inhibitory effect of Sanguisorba officinalis ethanol extract on NO and PGE production is mediated by suppression of NF-kappaB and AP-1 activation signaling cascade. J Ethnopharmacol 2011;134:11-17.
38. Yu T, Lee J, Lee YG, Byeon SE, Kim MH, Sohn EH, Lee YJ, Lee SG, Cho JY: In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum. J Ethnopharmacol 2010;128:139-147.
39. Bustamante J, Boisson-Dupuis S, Jouanguy E, Picard C, Puel A, Abel L, Casanova JL: Novel primary immunodeficiencies re-vealed by the investigation ofpaediatric infectious diseases. Curr Opin Immunol 2008;20:39-48.
40. von Bernuth H, Puel A, Ku CL, Yang K, Bustamante J, Chang HH, Picard C, Casanova JL: Septicemia without sepsis: inherited disorders of nuclear factor-kappa B-mediated inflammation. Clin Infect Dis 2005;41 Suppl 7:S436-S439. (Pubitemid 41598301)
41. Kim MH, Yoo DS, Lee SY, Byeon SE, Lee YG, Min T, Rho HS, Rhee MH, Lee J, Cho JY: The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contrib-uting to its broad-spectrum anti-inflammatory effects. Pharmazie 2011;66:293-300.
42. Lee YG, Chain BM, Cho JY: Distinct role of spleen tyrosine kinase in the early phosphorylation of inhibitor of kappaB alpha via activation of the phosphoinositide-3-kinase and Akt path-ways. Int J Biochem Cell Biol 2009;41:811-821.
43. Oh JY, Choi WS, Lee CH, Park HJ: The ethyl acetate extract of Cordyceps militaris inhibits IgE-mediated allergic responses in mast cells and passive cutaneous anaphylaxis reaction in mice. J Ethnopharmacol 2011;135:422-429.
44. Yu T, Lee S, Yang WS, Jang HJ, Lee YJ, Kim TW, Kim SY, Lee J, Cho JY: The ability of an ethanol extract of Cinnamomum cassia to inhibit Src and spleen tyrosine kinase activity contrib-utes to its anti-inflammatory action. J Ethnopharmacol 2012;139:566-573.
45. Wang L, Gordon RA, Huynh L, Su X, Park Min KH, Han J, Arthur JS, Kalliolias GD, Ivashkiv LB: Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity 2010;32: 518-530.
46. Ulanova M, Asfaha S, Stenton G, Lint A, Gilbertson D, Schreiber A, Befus D: Involvement of Syk protein tyrosine kinase in LPS-induced responses in macrophages. J Endotoxin Res 2007;13: 117-125. (Pubitemid 47471328)
47. Chaudhary A, Fresquez TM, Naranjo MJ: Tyrosine kinase Syk associates with toll-like receptor 4 and regulates sig-naling in human monocytic cells. Immunol Cell Biol 2007;85: 249-256. (Pubitemid 46701428)
48. Casals-Casas C, Alvarez E, Serra M, de la Torre C, Farrera C, Sanchez-Tillo E, Caelles C, Lloberas J, Celada A: CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activation versus proliferation. Eur J Immunol 2009;39:1902-1913.
49. Proffitt J, Crabtree G, Grove M, Daubersies P, Bailleul B, Wright E, Plumb M: An ATF/CREB-binding site is essential for cell-specific and inducible transcription of the murine MIP-1 beta cytokine gene. Gene 1995;152:173-179.
50. Xiong Y, Qiu F, Piao W, Song C, Wahl LM, Medvedev AE: Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activa-tion, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and I?B kinase gamma and increases A20 expression. J Biol Chem 2011;286:7905-7916.
51. Bischoff SC: Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 2008;11: 733-740.
52. Kwon JH, Kim JH, Choi SE, Park KH, Lee MW: Inhibitory effects of phenolic compounds from needles of Pinus densiflora on nitric oxide and PGE2 production. Arch Pharm Res 2010; 33:2011-2016.
53. Schetter AJ, Heegaard NH, Harris CC: Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 path-ways. Carcinogenesis 2010;31:37-49.
54. Khatami M: 'Yin and Yang' in inflammation: duality in innate immune cell function and tumorigenesis. Expert Opin Biol Ther 2008;8:1461-1472.
55. Karin M: The IkappaB kinase\-a bridge between inflammation and cancer. Cell Res 2008;18:334-342. (Pubitemid 351333897)
56. Okamoto M, Kawai K, Reznikoff CA, Oyasu R: Transformation in vitro of a nontumorigenic rat urothelial cell line by hydrogen peroxide. Cancer Res 1996;56:4649-4653. (Pubitemid 26338065)
57. Ohno S, Inagawa H, Dhar DK, Fujii T, Ueda S, Tachibana M, Ohno Y, Suzuki N, Inoue M, Soma G, Nagasue N: Role of tumor-associated macrophages (TAM) in advanced gastric car-cinoma: the impact on FasL-mediated counterattack. Anticancer Res 2005;25:463-470. (Pubitemid 40470051)
58. Jeong TY, Park BK, Lee YW, Cho CK, Yoo HS: Prospective analysis on survival outcomes of nonsmall cell lung cancer stages over IIIb treated with HangAm-Dan. Zhongguo Fei Ai Za Zhi 2010;13:1009-1015.